Time from recently RM date to recruitment and creatinine-adjusted urinary BPA concentration (μg/g Cr)^*.

<p>* Wilcoxon χ² = 6.48, <i>P</i> = 0.090</p><p>Time from recently RM date to recruitment and creatinine-adjusted urinary BPA concentration (μg/g Cr)^{<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0127886#t005fn001" target="_blank">*</a>}.</p

Demographic characteristics of the RM patients and the controls^*.

<p>*The values for age, number of RM and BMI are expressed as the mean ± SD. BMI = body mass index (kg/m²).</p><p>Demographic characteristics of the RM patients and the controls^{<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0127886#t001fn001" target="_blank">*</a>}.</p

Distribution of urinary BPA levels in controls, two and three or more RM patients.

<p>* n = detection of total number</p><p>^<b>†</b> Adjustment for creatinine-adjusted BPA</p><p>^# for creatinine-adjusted BPA</p><p>a, b: In the method of SNK analysis, there was not statistically significant difference with the same letters (a, b) (<i>P</i>>0.05); There was statistically significant difference with the different letters (a, b) (<i>P</i> <0.05).</p><p>Distribution of urinary BPA levels in controls, two and three or more RM patients.</p

Chromatogram of BPA standard (1ng/ml) (a), one RM patient’s urine sample (0.7ng/ml) (b) and one control patient’s urine sample (0.61ng/ml) (c).

<p>Chromatogram of BPA standard (1ng/ml) (a), one RM patient’s urine sample (0.7ng/ml) (b) and one control patient’s urine sample (0.61ng/ml) (c).</p

Distribution of non-creatinine-adjusted (a) and creatinine-adjusted (b) urinary BPA concentration in the RM patients and the controls.

<p>Distribution of non-creatinine-adjusted (a) and creatinine-adjusted (b) urinary BPA concentration in the RM patients and the controls.</p